EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
Vasconcelos, Pedro E.N.S., Gergis, Carol, Viray, Hollis, Varkaris, Andreas, Fujii, Masanori, Rangachari, Deepa, VanderLaan, Paul A., Kobayashi, Ikei S., Kobayashi, Susumu S., Costa, Daniel B.
Published in JTO clinical and research reports (01.09.2020)
Published in JTO clinical and research reports (01.09.2020)
Get full text
Journal Article
Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations
Vasconcelos, Pedro E.N.S., Kobayashi, Ikei S., Kobayashi, Susumu S., Costa, Daniel B.
Published in JTO clinical and research reports (01.03.2021)
Published in JTO clinical and research reports (01.03.2021)
Get full text
Journal Article
Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment
Mattos, Karen P. H, Gouvêa, Isabela R., Quintanilha, Júlia C. F., Cursino, Maria A., Vasconcelos, Pedro E. N. S., Moriel, Patricia
Published in Journal of clinical pharmacy and therapeutics (01.06.2019)
Published in Journal of clinical pharmacy and therapeutics (01.06.2019)
Get full text
Journal Article
miRNAs as biomarkers of adverse drug reactions to platinum-based agents in patients with non-small-cell lung cancer
Vasconcelos, Pedro Ens, Visacri, Marília B, Pincinato, Eder de C, Torso, Nadine de G, Seguin, Cecília S, Zambon, Lair, Barbeiro, Aristóteles de S, Junior, Maurício Wp, Moriel, Patricia
Published in Biomarkers in medicine (01.09.2021)
Published in Biomarkers in medicine (01.09.2021)
Get full text
Journal Article